Date:5/13/2010

and 2009 (Unaudited) (Expressed in U.S. Dollars) Three months ended March 31 2010 2009 Sales $4,443,899 $6,566,099 Cost of sales - (exclusive of depreciation of land-use rights and amortization of licenses and permits of $104,793 (2009-$104,633 ) 883,475 1,447,770 Gross profit 3,560,424 5,118,329 Selling, general and administrative expenses 3,092,248 3,547,623 Research and development expenses - net of $17,554 (2009 - $58,311) in government research grants 907,959 759,441 Depreciation of property, plant and equipment and amortization of licenses and permits 425,427 164,869 Total operating expenses 4,425,634 4,471,933 Operating income (loss) -865,210 646,396 Interest and financing expenses -124,375 -126,200 Interest income and other income (expenses) -492,592 93,131 Income (loss) before income taxes and non-controlling interests -1,482,177 613,327 Income tax recovery (expenses) 269,479 -481,768 Consolidated net income (loss) for the period -1,212,698 131,559 Loss (income) attributable to non - controlling interests 905,388 -106,880 Net income (loss) attributable to stockholders $-307,310 $24,679
'/>"/>

SOURCE Sinovac Biotech Ltd. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Related biology technology :

1. Sinovac to Host Conference Call to Report First Quarter 2010 Financial Results
2. Sinovac Announces Upsizing and Pricing of Common Share Offering
3. Sinovac Files Clinical Trial Application with SFDA for Vaccine Against Hand, Foot, and Mouth Disease
4. Sinovacs CEO Weidong Yin Presented with Annual Innovation Award by China Central Television
5. Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities
6. Sinovac Reports Unaudited Third Quarter 2009 Financial Results
7. Sinovac Obtains Third H1N1 Vaccine Order from Chinese Central Government
8. Sinovac Receives Certificate of Approval to Distribute Panflu (H5N1) Vaccine in Hong Kong
9. Sinovac to Present at 2009 UBS Global Life Sciences Conference
10. Sinovac Obtains Lot Release Certificate for Its First Batch of H1N1 Vaccine
11. Sinovac Obtains Initial Order of H1N1 Vaccine from Chinese Central Government